ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Global Health

FDA approves its first Ebola vaccine

by Megha Satyanarayana
January 3, 2020 | APPEARED IN VOLUME 98, ISSUE 1

 

The US Food and Drug Administration has approved an Ebola vaccine for the first time. The vaccine, Ervebo, is produced by Merck & Co. and was tested during a recent outbreak in West Africa. It has been administered more than 223,000 times during the current outbreak in the Democratic Republic of the Congo, where it is being used on an experimental basis. Ervebo is made from a live but weakened virus engineered to express an Ebola protein. The European Commission previously approved the vaccine.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment